Isabel Cassetti

2.3k total citations
48 papers, 1.1k citations indexed

About

Isabel Cassetti is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Isabel Cassetti has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 17 papers in Epidemiology and 16 papers in Virology. Recurrent topics in Isabel Cassetti's work include HIV/AIDS Research and Interventions (25 papers), HIV/AIDS drug development and treatment (20 papers) and HIV Research and Treatment (16 papers). Isabel Cassetti is often cited by papers focused on HIV/AIDS Research and Interventions (25 papers), HIV/AIDS drug development and treatment (20 papers) and HIV Research and Treatment (16 papers). Isabel Cassetti collaborates with scholars based in Argentina, United States and Brazil. Isabel Cassetti's co-authors include Arnaldo Etzel, Andrew Cheng, Jamal Suleiman, Lijie Zhong, Jeffrey Enejosa, Pedro Cahn, Diego Cecchini, Deborah L. Jones, Pablo Bonvehí and Kiat Ruxrungtham and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

Isabel Cassetti

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Cassetti Argentina 15 875 517 334 258 82 48 1.1k
Rebecca Lodwick United Kingdom 14 699 0.8× 379 0.7× 309 0.9× 380 1.5× 26 0.3× 22 1.1k
Michelle Moorhouse South Africa 15 1.1k 1.2× 528 1.0× 460 1.4× 409 1.6× 13 0.2× 46 1.4k
Kathleen Melbourne United States 13 898 1.0× 543 1.1× 1.1k 3.3× 180 0.7× 18 0.2× 28 1.5k
Marco Floridia Italy 19 935 1.1× 373 0.7× 334 1.0× 362 1.4× 16 0.2× 99 1.2k
Ian R. McNicholl United States 16 604 0.7× 240 0.5× 379 1.1× 310 1.2× 13 0.2× 31 942
Salvatore Nappa Italy 10 428 0.5× 180 0.3× 210 0.6× 202 0.8× 11 0.1× 22 794
Polly Clayden United States 14 898 1.0× 372 0.7× 451 1.4× 277 1.1× 7 0.1× 30 1.1k
J. Gonzalez-Lahoz Spain 8 906 1.0× 469 0.9× 244 0.7× 231 0.9× 37 0.5× 9 1.0k
Michael J. Vinikoor United States 20 635 0.7× 271 0.5× 251 0.8× 588 2.3× 23 0.3× 81 1.1k
José L. López-Colomés Spain 9 652 0.7× 260 0.5× 365 1.1× 227 0.9× 9 0.1× 13 857

Countries citing papers authored by Isabel Cassetti

Since Specialization
Citations

This map shows the geographic impact of Isabel Cassetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Cassetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Cassetti more than expected).

Fields of papers citing papers by Isabel Cassetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Cassetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Cassetti. The network helps show where Isabel Cassetti may publish in the future.

Co-authorship network of co-authors of Isabel Cassetti

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Cassetti. A scholar is included among the top collaborators of Isabel Cassetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Cassetti. Isabel Cassetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cecchini, Diego, et al.. (2023). Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV. Viruses. 15(5). 1127–1127. 1 indexed citations
3.
Sued, Omar, Diego Cecchini, María José Rolón, et al.. (2022). A small cluster randomised clinical trial to improve health outcomes among Argentine patients disengaged from HIV care. The Lancet Regional Health - Americas. 13. 100307–100307. 2 indexed citations
4.
5.
Jones, Deborah L., Jamile Ballivian, Violeta J. Rodriguez, et al.. (2021). Mental Health, Coping, and Social Support Among People Living with HIV in the Americas: A Comparative Study Between Argentina and the USA During the SARS-CoV-2 Pandemic. AIDS and Behavior. 25(8). 2391–2399. 31 indexed citations
6.
Cecchini, Diego, et al.. (2019). Resistance to HIV integrase strand transfer inhibitors in Argentina: first interim survey.. Revista Española de Quimioterapia. 32(3). 263–267. 2 indexed citations
7.
Cecchini, Diego, et al.. (2019). Resistencia a inhibidores de la integrasa en Argentina: primera encuesta interina. Revista española de quimioterapia. Suplemento. 32(3). 263–267. 1 indexed citations
8.
Rodriguez, Violeta J., Omar Sued, Diego Cecchini, et al.. (2019). Suicidal Ideation Among Adults Re-engaging in HIV Care in Argentina. AIDS and Behavior. 23(12). 3427–3434. 9 indexed citations
9.
10.
Baran, Robert W., Fiona Mulcahy, Ivanka Krznaric, et al.. (2014). Reduced HIV symptoms and improved health‐related quality of life correlate with better access to care for HIV‐1 infected women: the ELLA study. Journal of the International AIDS Society. 17(4S3). 19616–19616. 9 indexed citations
11.
Cahn, Pedro, Julio Montaner, Patricia Patterson, et al.. (2011). Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1st PI-Based Regimen. PLoS ONE. 6(8). e23726–e23726. 16 indexed citations
12.
Cahn, Pedro, Javier Altclas, Marcelo Martins, et al.. (2010). Antiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy. HIV Medicine. 12(6). 334–342. 2 indexed citations
13.
Valverde, Eduardo, et al.. (2009). Sex Risk Practices among HIV-Positive Individuals in Buenos Aires, Argentina. AIDS Patient Care and STDs. 23(7). 551–556. 14 indexed citations
14.
Mills, Anthony, Mark Nelson, Dushyantha Jayaweera, et al.. (2009). Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis. AIDS. 23(13). 1679–1688. 199 indexed citations
15.
Cahn, Pedro, Javier Altclas, Maria Isabel Morgan Martins, et al.. (2008). O414 48-week data from Study AVX-201 – a randomised phase IIb study of apricitabine in treatment-experienced patients with M184V and NRTI resistance. Journal of the International AIDS Society. 11(S1). 4 indexed citations
16.
Pessôa, Mário Guimarães, Brian Gazzard, Carlos Eduardo Brandão‐Mello, et al.. (2008). Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy. AIDS. 22(14). 1779–1787. 33 indexed citations
17.
Scapellato, Pablo, et al.. (2008). Rosuvastatina para tratamiento de la dislipidemia en pacientes infectados con VIH en tratamiento antirretroviral de gran actividad. Experiencia preliminar. Enfermedades Infecciosas y Microbiología Clínica. 26(6). 325–329. 10 indexed citations
18.
Cahn, Pedro, Isabel Cassetti, Robin Wood, et al.. (2006). Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients. AIDS. 20(9). 1261–1268. 33 indexed citations
19.
Scapellato, Pablo, et al.. (2004). Osteonecrosis en pacientes infectados por HIV. Medicina-buenos Aires. 64(4). 325–331. 3 indexed citations
20.
Baum, Marianna K., Gail Shor‐Posner, Pablo Bonvehí, et al.. (1992). Influence of HIV Infection on Vitamin Status and Requirementsa. Annals of the New York Academy of Sciences. 669(1). 165–173. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca Lodwick Breakdown of academic impact, for papers by Michelle Moorhouse Breakdown of academic impact, for papers by Kathleen Melbourne Breakdown of academic impact, for papers by Marco Floridia Breakdown of academic impact, for papers by Ian R. McNicholl Breakdown of academic impact, for papers by Salvatore Nappa Breakdown of academic impact, for papers by Polly Clayden Breakdown of academic impact, for papers by J. Gonzalez-Lahoz Breakdown of academic impact, for papers by Michael J. Vinikoor Breakdown of academic impact, for papers by José L. López-Colomés
Rankless by CCL
2026